Product Information |
BR-1420_PI_01.pdf
|
Registration Number |
BR-1420
|
Generic Name |
Insulin Degludec + Liraglutide
|
Brand Name |
Xultophy
|
Dosage Strength |
100 U/3.6mg per mL
|
Dosage Form |
Solution For Injection (SC)
|
Classification |
Prescription Drug (RX)
|
Packaging |
3 mL Type I glass cartridge with bromobutyl and
isoprene laminate rubber and red bromobutyl rubber plunger assembled in a pen injector (Box of 5's)
|
Pharmacologic Category |
Antidiabetics
|
Manufacturer |
Novo Nordisk Pharmaceutical Industries, LP
|
Country of Origin |
United States of America
|
Trader |
Novo Nordisk A/S
|
Importer |
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Distributor |
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Application Type |
Initial
|
Issuance Date |
20 September 2022
|
Expiry Date |
20 September 2027
|